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function decreases, leading to a cellular 
crisis that is characterized by reduced 
cell growth, G1 cell cycle arrest, and dam-
age or loss of mtDNA (Figure 1). The loss 
of mitochondrial genome has pleiotropic 
effects, including the decrease in inner 
mitochondrial membrane potential. As 
a result, transport of molecules into and 
out of the mitochondrial matrix is defec-
tive, leading to impaired Fe-S cluster bio-
genesis. The authors speculate that one 
or more proteins that bind Fe-S, such as 
Rad3 helicase, Pri2 primase, or Ntg2 gly-
cosylase, may be critical for genome sta-
bility.
A number of compelling questions 
remain. What is the underlying mecha-
nism leading to the decrease in mito-
chondrial function with aging? How might 
the mechanisms by which cells escape 
this crisis relate to the proliferation of 
cancer cells? Both historic and recent 
studies underscore the connections 
between mitochondrial function, cellular 
metabolism, and cancer cell proliferation 
(Warburg, 1956; Wallace, 2005). Perhaps 
changes in the metabolism of Fe, or other 
minerals, should be further explored as 
critical mediators of genetic changes in 
human disease.
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The activation process for the epidermal growth factor receptor (EGFR) involves formation of an 
asymmetric dimer of the tyrosine kinase domains. Jura et al. (2009) in this issue and Brewer et al. 
(2009) in Molecular Cell now demonstrate that the juxtamembrane region of EGFR plays a crucial 
role in stabilizing this dimer.
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Stevan R. Hubbard *The epidermal growth factor receptor 
(EGFR), also known as ErbB1 or HER1, 
together with three related receptors, 
ErbB2/HER2, ErbB3/HER3, and ErbB4/
HER4, constitute a subgroup of the 
receptor tyrosine kinase family of cell 
surface receptors. Receptors of the 
EGFR subgroup are critical compo-
nents of signaling pathways that govern 
cell growth and differentiation during 
embryogenesis and adult homeosta-
sis (Schlessinger, 2002). Hyperactivity 
of these receptors, either by mutation 
or overexpression of ligand or receptor, 
contributes to a variety of human can-
cers (Sergina and Moasser, 2007). Find-ings by Jura et al. (2009) and Brewer et 
al. (2009) provide new insights into the 
EGFR activation process, highlighting 
the role of the juxtamembrane region, 
the cytoplasmic segment of the receptor 
that connects the transmembrane helix 
to the tyrosine kinase domain.
In the “classical” scenario for recep-
tor tyrosine kinase activation, a homodi-
meric ligand binds symmetrically to the 
ectodomains of two receptors, juxta-
posing the cytoplasmic kinase domains 
for autophosphorylation (in trans) on 
tyrosine residues, which stimulates cata-
lytic activity and creates docking sites for 
signaling proteins (Schlessinger, 2000). Cell 1Although EGFR was the first receptor 
tyrosine kinase to be discovered (Car-
penter et al., 1978), its activation mecha-
nisms have proven to be “nonclassical” 
at nearly every step. Unlike the dimeric 
ligands for other receptor tyrosine 
kinases, EGF is monomeric and forms 
a 1:1 complex with the EGFR ectodo-
main. Receptor dimerization is enabled 
through a conformational change in the 
ectodomain induced by ligand binding 
(Burgess et al., 2003) (Figure 1).
The mechanism of EGFR kinase acti-
vation in the ligand-stabilized receptor 
dimer also differs from the canonical 
mechanism, in which the two juxtaposed 37, June 26, 2009 ©2009 Elsevier Inc. 1181
kinase domains autophosphorylate spe-
cific tyrosine residues in the kinase acti-
vation loop, the juxtamembrane region, 
and the region C-terminal to the kinase 
domain. Because of the divergent spatial 
positions of these sites, it is unlikely that 
the kinase domains form a stable dimer 
during the autophosphorylation process; 
some form of kinase “gymnastics” would 
seem to be required, a job better suited 
figure 1. The Active eGf-eGfR Dimer
A model of the 2:2 complex of epidermal growth 
factor (EGF; orange) and its receptor (EGFR; 
individual molecules in the dimer are shown as 
magenta and cyan). Shown are the four subdo-
mains (I–IV) of the EGFR ectodomain (see Bur-
gess et al., 2003) and the transmembrane helices 
(rectangles; here, shown interacting). In the cyto-
plasm, the two tyrosine kinase domains form an 
asymmetric dimer, with the C-terminal lobe (C) of 
the activator/donor kinase (cyan) interacting with 
the N-terminal lobe (N) of the receiver/acceptor 
kinase (magenta), leading to activation of the lat-
ter (Zhang et al., 2006). In the model presented 
by Jura et al. (2009), the juxtamembrane segment 
JM-A forms an antiparallel helical dimer to facili-
tate formation of the asymmetric kinase dimer. 
Jura et al. (2009) and Brewer et al. (2009) both 
suggest that the juxtamembrane segment JM-B/
JMAD of the receiver/acceptor kinase makes 
stabilizing contacts with the C-terminal lobe of 
the activator/donor kinase. The spatial disposi-
tion of JM-B/JMAD of the activator/donor kinase 
is unknown and not thought to be of functional 
consequence.1182 Cell 137, June 26, 2009 ©2009 Elsevieto monomeric kinase domains. In con-
trast to most receptor tyrosine kinases, 
EGFR is not activated by autophospho-
rylation of the activation loop. In fact, 
all of the tyrosine autophosphorylation 
sites reside in its extensive C-terminal 
tail, which would presumably not require 
the same degree of autophosphoryla-
tion “gymnastics.” Instead, the EGFR 
kinase domains form a (relatively) stable 
homodimer, resembling the heterodi-
mer formed between cyclin-dependent 
kinase-2 (CDK2) and its protein activa-
tor, cyclin A (Zhang et al., 2006). In this 
asymmetric homodimer, one EGFR 
kinase domain plays the role of cyclin 
A (the activator/donor), and the other 
kinase domain plays the role of CDK2 
(the receiver/acceptor) (Figure 1). Only 
the receiver kinase domain is imbued 
with catalytic activity, and proceeds to 
phosphorylate tyrosine residues in the 
C-terminal tail of the receptor (whether 
in cis or trans, or both, is not known).
These findings set the stage for 
the current act in the EGFR activation 
drama: enter the juxtamembrane region. 
The juxtamembrane region in several 
receptor tyrosine kinases (such as Kit 
and the ephrin receptors) functions as an 
autoinhibitory segment, which is relieved 
through tyrosine phosphorylation therein 
(Hubbard, 2004). As the new reports by 
Jura et al. (2009) and Brewer et al. (2009) 
demonstrate, the juxtamembrane region 
of EGFR is neither autoinhibitory nor 
neutral, but acts in an essential posi-
tive manner to stabilize formation of the 
asymmetric kinase dimer—yet another 
departure from the standard script.
As a structural starting point for their 
investigations, Jura et al. (2009) use the 
available crystal structure of the HER4 
kinase domain, in which much of the 
juxtamembrane region is present in the 
construct and ordered in the structure. 
Brewer et al. (2009) crystallize their own 
EGFR cytoplasmic protein containing 
the full juxtamembrane region. In both 
cases, the structures show the now 
readily recognized asymmetric kinase 
dimer, with the C-terminal lobe of the 
activator kinase abutting the N-terminal 
lobe of the receiver kinase. The bonus 
feature in these structures is the behav-
ior of the juxtamembrane region of the 
receiver kinase, which wraps around the 
C-terminal lobe of the activator kinase r Inc.(Figure 1). Mutagenesis on both sides 
of the interface provides compelling evi-
dence that this juxtamembrane segment 
(designated JM-B or JMAD) indeed sta-
bilizes the activated dimer via the inter-
actions viewed in the crystal structures. 
An EGFR-activating mutation found in 
non-small cell lung cancers (valine 665 
to methionine) can now be rationalized 
from these structural findings (Brewer et 
al., 2009).
JM-B/JMAD comprises residues 
664–682, with the kinase domain begin-
ning immediately thereafter. What about 
the membrane-proximal segment of 
the juxtamembrane region, residues 
645–663, designated JM-A? The first 
nine residues (645–653) are nearly all 
basic, and these are followed by an 
EGFR family-conserved sequence: 
LRRLL (leucine or another hydrophobic 
residue). Jura et al. (2009) posit that this 
motif is helical and forms an antiparallel 
dimer with JM-A in the other EGFR mol-
ecule (within the EGF-stabilized dimer), 
for the purpose of facilitating formation 
of the asymmetric kinase dimer. As evi-
dence, deletion of JM-A from either the 
receiver or activator molecule (using 
an elegant complementation strat-
egy) results in a marked impairment of 
kinase activity in vitro (Jura et al., 2009). 
Moreover, their measurements using 
nuclear magnetic resonance on a pep-
tide encompassing this region confirm 
the potential for JM-A to form an anti-
parallel helical dimer.
Intriguingly, the new crystal struc-
ture of the EGFR cytoplasmic domain 
reported by Brewer et al. (2009), unlike 
the HER4 structure analyzed by Jura et 
al. (2009) (which lacks JM-A in the con-
struct), contains a mostly ordered JM-A, 
and indeed the LRRLL motif is helical. 
Conspicuously absent, though, is a heli-
cal dimer; the JM-A helix points away 
from the C-terminal lobe of the activator 
kinase and makes lattice contacts that 
likely have no functional significance. 
The crystal structure of Brewer et al. 
(2009) would thus seem to cast some 
doubt on the JM-A helical-dimer hypoth-
esis. However, it is certainly conceivable 
that, without the tethering of JM-A to the 
nearby transmembrane helix (lacking in 
the crystallized protein), the helical dimer 
is not sufficiently stable energetically to 
overcome the entropic costs.
Finally, Jura et al. (2009) determine 
a crystal structure of an EGFR kinase 
domain (valine 924 to arginine) that is 
unable to form the activated kinase 
dimer, which reveals yet another poten-
tial regulatory mechanism for EGFR—in 
this case, inhibitory. In this new structure, 
a symmetric kinase dimer is observed in 
which the C-terminal tail of EGFR par-
tially masks the site on its own C-termi-
nal lobe to which the JM-B segment will 
bind (in trans) for activation. This inhibi-
tory dimer could be the molecular basis 
for reports of preformed, nonsignaling 
EGFR dimers on the cell surface.
Other activation mechanisms involv-
ing JM-A have been proposed, includ-
ing an electrostatic switch triggered by 
the binding of calmodulin (McLaughlin 
et al., 2005). To add to the regulatory 
complexity, phosphorylation of threo-
nine 654 in JM-A by protein kinase C is 
known to be inhibitory, but exactly how 
is still an open question. Furthermore, 
the model presented by Jura et al. During development, epithelial tissues 
are extensively remodeled while main-
taining their polarized architecture. A 
well-studied example is dorsal closure in 
embryos of the fruit fly Drosophila. Dur-
ing dorsal closure the lateral ectoderm 
migrates as a sheet toward the dorsal 
midline (Figure 1). Cells at the leading 
edge accumulate high levels of actin and 
myosin II at their front, forming a supra-
closing in on M
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It remains largely unknown how
the interplay of different tensile 
now report that a ratchet-like m
closure in embryos of the fruit fly(2009) for the EGF-triggered transition 
from the inactive kinase dimer (lack-
ing a JM-A helical dimer) to the active 
kinase dimer (with a JM-A helical dimer) 
assumes that the EGFR transmem-
brane helices become closely apposed 
(Figure 1), for which there is reasonable 
but not conclusive evidence. Thus, 
there are several issues regarding the 
EGFR signal-transduction mechanism 
that remain to be resolved.
By understanding all of the ins and 
outs of EGFR activation, there is hope 
that these mechanistic details can be 
exploited in the design of cancer thera-
peutics, either through targeting the 
ectodomain via antibodies or the kinase 
domain via small molecules. Indeed, 
recent advances in both therapeutic 
modalities provide reason for optimism 
(Sergina and Moasser, 2007). Much as 
the tale of EGFR activation has unfolded 
scene by scene, we can be assured that 
each receptor tyrosine kinase will have 
its own story to tell.Cell 1
cellular actin cable that contracts to pro-
duce “purse-string” tension. Simultane-
ously, the underlying dorsal squamous 
epithelium called amnioserosa contracts 
and pulls the lateral ectoderm (Hutson 
et al., 2003). Solon et al. (2009) now 
shed new light on how these two steps 
are coordinated. They show that pulsed 
contractile forces produced by amnio-
serosa cells are stabilized by epidermal 
echanisms of T
diterranée, Campus de Luminy case 907, 1328
 large-scale tissue movements du
forces associated with actomyos
echanism drives the movement o
 Drosophila.RefeRences
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actin cables to drive the movement of 
the epithelial sheet during dorsal closure 
in a ratchet-like mechanism.
Tissue remodeling relies on changes 
in cell shape as a result of forces gen-
erated by actomyosin cytoskeletal net-
works and the transmission of these 
forces at the cell cortex by adhesion 
molecules (Lecuit and Lenne, 2007). For 
instance, myosin II-based tension drives 
issue 
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ring development emerge from 
in networks. Solon et al. (2009) 
f epithelial sheets during dorsal 
